Atul Ltd 2018-19

Note 28.13 Loans Disclosures pursuant to the Regulation 34(3) read with para A of Schedule V to the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with Section 186(4) of the Companies Act, 2013. ( ` cr) Particulars Purpose Amount outstanding as at Maximum balance during the year March 31, 2019 March 31, 2018 2018-19 2017-18 i) Subsidiary companies: Atul Bioscience Ltd Seed funding support as promoters - - - ǪȦǩǦ Amal Ltd * Interest free loan, pursuant to Board for Industrial and Financial Reconstruction order ǪȦǯǨ 7.07 7.07 7.89 * at amortised cost a) Loans given to employees as per the policy of the Company are not considered. b) The loanees did not hold any shares in the share capital of the Company. Note 28.14 Disclosure requirement under MSMED Act, 2006 The Company has certain dues to suppliers (trade and capital) registered under Micro, Small and Medium Enterprises Development Act, 2006 (‘MSMED Act’). The disclosures pursuant to the said MSMED Act are as follows: ( ` cr) Particulars As at March 31, 2019 As at March 31, 2018 Principal amount due to suppliers registered under the MSMED Act and remaining unpaid as at year end ǭȦǨǪ ǪȦǦǬ Interest due to suppliers registered under the MSMED Act and remaining unpaid as at year end 0.01 0.02 Principal amounts paid to suppliers registered under the MSMED Act, beyond the appointed day during the year 1.11 ǧȦǧǪ Interest paid, other than under Section 16 of MSMED Act, to suppliers registered under the MSMED Act, beyond the appointed day during the year - - Interest paid, under Section 16 of MSMED Act, to suppliers registered under the MSMED Act, beyond the appointed day during the year 0.02 0.02 Interest due and payable towards suppliers registered under MSMED Act, for payments already made - - Further interest remaining due and payable for earlier years - - Note 28.15 Expenditure on Corporate Social Responsibility initiatives a) Gross amount required to be spent by the Company during the year is ` 7.90 cr b) Amount spent during the year on: ( ` cr) Particulars Paid Payable Total i) Construction | Acquisition of any asset - - - ii) On purposes other than (i) above 7.90 - 7.90 171 Standalone | Notes to the Financial Statements